My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 148

    1.

    Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background.

    Fornoni A, Striker LJ, Zheng F, Striker GE.

    Diabetes. 2002 Feb;51(2):499-505.PMID: 11812761 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Matrix accumulation in mesangial cells exposed to cyclosporine A requires a permissive genetic background.

    Fornoni A, Lenz O, Tack I, Potier M, Elliot SJ, Striker LJ, Striker GE.

    Transplantation. 2000 Aug 27;70(4):587-93.PMID: 10972214 [PubMed - indexed for MEDLINE]Related articles

    3.

    Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.

    Okada M, Takemura T, Yanagida H, Yoshioka K.

    Kidney Int. 2002 Jan;61(1):113-24.PMID: 11786091 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.

    Krag S, Nyengaard JR, Wogensen L.

    Nephrol Dial Transplant. 2007 Sep;22(9):2485-96. Epub 2007 Apr 23.PMID: 17452404 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    High glucose level unmasks a genetic predisposition to enhanced extracellular matrix production in mesangial cells from the Milan normotensive strain.

    Pugliese G, Pricci F, Menè P, Romeo G, Nofroni I, Giannini S, Cresci B, Galli G, Rotella CM, Di Mario U, Pugliese F.

    J Am Soc Nephrol. 1997 Mar;8(3):406-14.PMID: 9071709 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Role of angiotensin II in glucose-induced inhibition of mesangial matrix degradation.

    Singh R, Alavi N, Singh AK, Leehey DJ.

    Diabetes. 1999 Oct;48(10):2066-73.PMID: 10512375 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    High glucose decreases matrix metalloproteinase-2 activity in rat mesangial cells via transforming growth factor-beta1.

    Singh R, Song RH, Alavi N, Pegoraro AA, Singh AK, Leehey DJ.

    Exp Nephrol. 2001;9(4):249-57.PMID: 11423724 [PubMed - indexed for MEDLINE]Related articles

    8.

    Expression of transforming growth factor-beta 1 by pancreatic stellate cells and its implications for matrix secretion and turnover in chronic pancreatitis.

    Shek FW, Benyon RC, Walker FM, McCrudden PR, Pender SL, Williams EJ, Johnson PA, Johnson CD, Bateman AC, Fine DR, Iredale JP.

    Am J Pathol. 2002 May;160(5):1787-98.PMID: 12000730 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.

    Lee EA, Seo JY, Jiang Z, Yu MR, Kwon MK, Ha H, Lee HB.

    Kidney Int. 2005 May;67(5):1762-71.PMID: 15840023 [PubMed - indexed for MEDLINE]Related articles

    10.

    An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.

    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.

    Nephrol Dial Transplant. 2006 Sep;21(9):2406-16. Epub 2006 May 25.PMID: 16728425 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    TGF-beta receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain.

    Riser BL, Ladson-Wofford S, Sharba A, Cortes P, Drake K, Guerin CJ, Yee J, Choi ME, Segarini PR, Narins RG.

    Kidney Int. 1999 Aug;56(2):428-39.PMID: 10432381 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mechanical strain- and high glucose-induced alterations in mesangial cell collagen metabolism: role of TGF-beta.

    Riser BL, Cortes P, Yee J, Sharba AK, Asano K, Rodriguez-Barbero A, Narins RG.

    J Am Soc Nephrol. 1998 May;9(5):827-36.PMID: 9596080 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Monocyte/mesangial cell interactions in high-glucose co-cultures.

    Menè P, Caenazzo C, Pugliese F, Cinotti GA, D'Angelo A, Garbisa S, Gambaro G.

    Nephrol Dial Transplant. 2001 May;16(5):913-22.PMID: 11328895 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells.

    Ayo SH, Radnik RA, Garoni JA, Glass WF 2nd, Kreisberg JI.

    Am J Pathol. 1990 Jun;136(6):1339-48. Erratum in: Am J Pathol 1990 Aug;137(2):preceding 225. PMID: 2356864 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen.

    Jacot TA, Striker GE, Stetler-Stevenson M, Striker LJ.

    Lab Invest. 1996 Dec;75(6):791-9.PMID: 8973474 [PubMed - indexed for MEDLINE]Related articles

    16.

    Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.

    Peng Y, Liu H, Liu F, Liu Y, Li J, Chen X.

    Nephrology (Carlton). 2006 Dec;11(6):516-23.PMID: 17199790 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

    Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S.

    Kidney Int. 2002 Sep;62(3):901-13.PMID: 12164872 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Connective tissue growth factor mediates high glucose effects on matrix degradation through tissue inhibitor of matrix metalloproteinase type 1: implications for diabetic nephropathy.

    McLennan SV, Wang XY, Moreno V, Yue DK, Twigg SM.

    Endocrinology. 2004 Dec;145(12):5646-55. Epub 2004 Sep 2.PMID: 15345671 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy.

    McLennan SV, Martell SK, Yue DK.

    Diabetes. 2002 Aug;51(8):2612-8.PMID: 12145178 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Regulation of the expression and function of glucose transporter-1 by TGF-beta 1 and high glucose in mesangial cells]

    Zhang J, Liu Z, Liu H, Li Y, Li L.

    Chin Med J (Engl). 2000 Jun;113(6):508-13. Chinese. PMID: 11775867 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity